If a pharmaceutical company aims to reduce inflammation by targeting the NF-κB signaling pathway, which consequence involving cytokine production is most likely?

💡 Explanation

Inhibiting the NF-κB pathway reduces the expression of genes encoding pro-inflammatory cytokines like TNF-α and IL-6, because NF-κB is a key transcription factor for these cytokines. Therefore, the transcription of pro-inflammatory cytokines will decrease, rather than increase other inflammatory mediators like prostaglandins.

• If a patient shows very low reticulocyte count alongside anemia after kidney damage reduces erythropoietin production, which consequence follows regarding iron recycling?
• If intraocular pressure rises rapidly due to angle closure glaucoma, which consequence follows regarding lens curvature?
• If a patient with rheumatoid arthritis has increased levels of TNF-alpha, which consequence follows regarding inflammation?
• Why does anaphylactic shock, following a bee sting in a sensitized individual, primarily result in a sharp drop in blood pressure, rather than a localized inflammatory response?
• Why does the perception of chronic pain intensify even when the initial tissue damage has healed?
• During intense exercise, muscle tissue produces lactic acid. What causes hemoglobin's oxygen affinity to decrease in exercising muscle tissue?